These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29925445)

  • 1. Detection of IgG3 antibodies specific to the human immunodeficiency virus type 1 (HIV-1) p24 protein as marker for recently acquired infection.
    Viana IFT; Coêlho DF; Palma ML; Nascimento EJM; Gu G; Lima LFO; Foti L; Krieger MA; Pilcher C; Calzavara-Silva CE; Mailliard RB; Rinaldo CR; Dhalia R; Marques ETA
    Epidemiol Infect; 2018 Jul; 146(10):1293-1300. PubMed ID: 29925445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populations.
    Wilson KM; Johnson EI; Croom HA; Richards KM; Doughty L; Cunningham PH; Kemp BE; Branson BM; Dax EM
    AIDS; 2004 Nov; 18(17):2253-9. PubMed ID: 15577537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of early HIV-1 infection associates with plasmacytoid dendritic cell-reactive opsonophagocytic IgG antibodies to HIV-1 p24.
    Tjiam MC; Sariputra L; Armitage JD; Taylor JP; Kelleher AD; Tan DB; Lee S; Fernandez S; French MA
    AIDS; 2016 Nov; 30(18):2757-2765. PubMed ID: 27603291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal analysis of HIV-1-specific antibody responses.
    Curtis KA; Kennedy MS; Owen SM
    AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1099-105. PubMed ID: 25314631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of HIV-Gag p24-specific antibodies in sera and saliva of HIV-1-infected adults and in sera of infants born to HIV-1-infected mothers.
    Yasuda S; Iwasaki M; Oka S; Naganawa S; Nakasone T; Honda M; Sata T; Kojima A; Matsuda S; Takemori T; Tsunetsugu-Yokota Y
    Microbiol Immunol; 1998; 42(4):305-11. PubMed ID: 9623918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection.
    Yates NL; Lucas JT; Nolen TL; Vandergrift NA; Soderberg KA; Seaton KE; Denny TN; Haynes BF; Cohen MS; Tomaras GD
    AIDS; 2011 Nov; 25(17):2089-97. PubMed ID: 21832938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
    Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of anti-HIV IgG3, IgA and p24Ag in perinatally HIV-1 infected infants.
    Louisirirotchanakul S; Kanoksinsombat C; Likanonsakul S; Sunthornkachit R; Supanit I; Wasi C
    Asian Pac J Allergy Immunol; 2002 Jun; 20(2):99-104. PubMed ID: 12403194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of HIV-1 p24 at Attomole Level by Ultrasensitive ELISA with Thio-NAD Cycling.
    Nakatsuma A; Kaneda M; Kodama H; Morikawa M; Watabe S; Nakaishi K; Yamashita M; Yoshimura T; Miura T; Ninomiya M; Ito E
    PLoS One; 2015; 10(6):e0131319. PubMed ID: 26098695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extremely prolonged HIV seroconversion associated with an MHC haplotype carrying disease susceptibility genes for antibody deficiency disorders.
    Padiglione A; Aleksic E; French M; Arnott A; Wilson KM; Tippett E; Kaye M; Gray L; Ellett A; Crane M; Leslie DE; Lewin SR; Breschkin A; Birch C; Gorry PR; McPhee DA; Crowe SM
    Clin Immunol; 2010 Nov; 137(2):199-208. PubMed ID: 20696618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fourth-generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody.
    Saville RD; Constantine NT; Cleghorn FR; Jack N; Bartholomew C; Edwards J; Gomez P; Blattner WA
    J Clin Microbiol; 2001 Jul; 39(7):2518-24. PubMed ID: 11427563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new combined HIV p24 antigen and anti-HIV-1/2/O screening assay.
    Polywka S; Duttmann H; Lübben F; Laufs R; Feldner J
    Methods Mol Biol; 2005; 304():229-43. PubMed ID: 16061980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-Based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen.
    Tang S; Zhao J; Storhoff JJ; Norris PJ; Little RF; Yarchoan R; Stramer SL; Patno T; Domanus M; Dhar A; Mirkin CA; Hewlett IK
    J Acquir Immune Defic Syndr; 2007 Oct; 46(2):231-7. PubMed ID: 17693896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect estimates of HIV-1 incidence in a high-prevalence population.
    Cleghorn FR; Jack N; Murphy JR; Edwards J; Mahabir B; Paul R; O'Brien T; Greenberg M; Weinhold K; Bartholomew C; Brookmeyer R; Blattner WA
    Am J Epidemiol; 1998 May; 147(9):834-9. PubMed ID: 9583713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantification of the levels of p24 antigen and antibodies in human immunodeficiency virus infection].
    García F; Quirós E; Bernal MC; Alados JC; González MI; Maroto MC
    Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):75-8. PubMed ID: 1643142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Earlier diagnosis of HIV-1 infection by simultaneous detection of p24 antigen and antibody IgGs to p17 and reverse transcriptase in serum with enzyme immunoassay.
    Hashida S; Hashinaka K; Nishikata I; Saito A; Takamizawa A; Shinagawa H; Ishikawa E
    J Clin Lab Anal; 1996; 10(4):213-9. PubMed ID: 8811465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Monoclonal Antibodies against HIV-1 p24 Protein and Its Application in Colloidal Gold Immunochromatographic Assay for HIV-1 Detection.
    Ma Y; Ni C; Dzakah EE; Wang H; Kang K; Tang S; Wang J; Wang J
    Biomed Res Int; 2016; 2016():6743904. PubMed ID: 27069923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses.
    Velashjerdi Farahani S; Reza Aghasadeghi M; Memarnejadian A; Faezi S; Shahosseini Z; Mahdavi M
    Pathog Glob Health; 2016 Mar; 110(2):39-47. PubMed ID: 26403975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell epitopes of HIV type 1 p24 capsid protein: a reassessment.
    Janvier B; Lasarte JJ; Sarobe P; Hoebeke J; Baillou-Beaufils A; Borras-Cuesta F; Barin F
    AIDS Res Hum Retroviruses; 1996 Apr; 12(6):519-25. PubMed ID: 8679307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.